Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03011541 · ClinicalTrials.gov registry record · NA

Stem Cell Ophthalmology Treatment Study II

A NA study of Glaucoma and Age-related Macular Degeneration, sponsored by MD Stem Cells.

Recruiting
Registry status
NA
Development phase
500
Enrollment target
4
Study locations

NCT03011541 is a NA study of Glaucoma and Age-related Macular Degeneration that is actively recruiting participants, run by MD Stem Cells. The registered enrollment target is 500 participants, below the 905-participant average among 92 other Glaucoma trials with a reported enrollment target (45% lower). The trial reports 4 study locations across 4 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03011541, a NA study of Glaucoma and Age-related Macular Degeneration, is actively recruiting participants, sponsored by MD Stem Cells.

RECRUITING
Registry status
NA
Development phase
500 participants
Enrollment target
4
Study locations

Study Summary

This study will evaluate the use of autologous bone marrow derived stem cells (BMSC) for the treatment of retinal and optic nerve damage or disease.

Conditions Studied

Glaucoma Age-related Macular Degeneration Retinitis Pigmentosa Retinal Disease Stargardt Disease Optic Neuropathy Leber Hereditary Optic Neuropathy Optic Atrophy Nonarteritic Ischemic Optic Neuropathy Optic Nerve Disease

Interventions

  • PROCEDURE Arm 1

Study Locations (4)

Connecticut

  • MD Stem Cells - Westport

Florida

  • MD Stem Cells - Coral Springs

Austria

  • MD Stem Cells Kobinia Med - Vienna

United Arab Emirates

  • The Saudi-German Hospital - Dubai

Trial Details

FieldValue
Enrollment Target 500 participants
Start Date 2016-01
Est. Completion 2027-07-31
Phase NA

Sponsor

MD Stem Cells

3 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT03011541

The ClinicalTrials.gov registry entry for NCT03011541 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 500 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 905-participant average among 92 other Glaucoma trials with a reported enrollment target (45% lower). The listed sponsor is MD Stem Cells, which has 3 total studies on file at ClinicalTrials.gov.

The record links to 10 conditions, with Glaucoma appearing as the primary indexed condition, and to 1 intervention - of which Arm 1 is the first listed.

NCT03011541 reports 4 study locations spanning 4 distinct geographic areas - top geographies include Connecticut, Florida, Austria.

Frequently Asked Questions

What is clinical trial NCT03011541 about?

NCT03011541 is a clinical study titled "Stem Cell Ophthalmology Treatment Study II". This study will evaluate the use of autologous bone marrow derived stem cells (BMSC) for the treatment of retinal and optic nerve damage or disease.

What is the current status of trial NCT03011541?

This trial is currently recruiting. It is a NA study. The enrollment target is 500 participants. The study started on 2016-01. Estimated completion is 2027-07-31.

What conditions does trial NCT03011541 study?

This clinical trial studies the following conditions: Glaucoma, Age-related Macular Degeneration, Retinitis Pigmentosa, Retinal Disease, Stargardt Disease.

What interventions are being tested in trial NCT03011541?

The interventions under investigation include: Arm 1 (PROCEDURE).

Who is sponsoring clinical trial NCT03011541?

This trial is sponsored by MD Stem Cells, which has 3 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03011541 being conducted?

This trial has 4 study locations across Connecticut, Florida, Austria, United Arab Emirates. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Glaucoma

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Glaucoma

All registered trials for this condition

Age-related Macular Degeneration

All registered trials for this condition

Connecticut

All trials with a study site in Connecticut

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.